This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003:37:124-37.

doi: 10.1159/000071370.

Cyclooxygenase-2 and colorectal cancer

Raymond N DuBois¹

Affiliations

Affiliation

¹ Department of Medicine and Cell Biology, Vanderbilt University Medical Center, Department of Veterans Affairs Medical Center, Nashville, Tenn., USA. raymond.dubois@mcmail.vanderbilt.edu

PMID: 12795052
DOI: 10.1159/000071370

Review

Cyclooxygenase-2 and colorectal cancer

Raymond N DuBois. Prog Exp Tumor Res. 2003.

. 2003:37:124-37.

doi: 10.1159/000071370.

Author

Raymond N DuBois¹

Affiliation

¹ Department of Medicine and Cell Biology, Vanderbilt University Medical Center, Department of Veterans Affairs Medical Center, Nashville, Tenn., USA. raymond.dubois@mcmail.vanderbilt.edu

PMID: 12795052
DOI: 10.1159/000071370

No abstract available

PubMed Disclaimer

Similar articles

[Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M, Mohr L, Blum HE. Geissler M, et al. Dtsch Med Wochenschr. 2002 Jun 7;127(23):1256-8. doi: 10.1055/s-2002-32104. Dtsch Med Wochenschr. 2002. PMID: 12053285 German. No abstract available.
[Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C, Meary N. Florent C, et al. Bull Cancer. 2004 May;91 Spec No:S85-8. Bull Cancer. 2004. PMID: 15239335 Review. French.
Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
Chau I, Cunningham D. Chau I, et al. N Engl J Med. 2002 Apr 4;346(14):1085-7. doi: 10.1056/NEJM200204043461412. N Engl J Med. 2002. PMID: 11932478 No abstract available.
COX-2 inhibitors cut risk of colon polyps.
[No authors listed] [No authors listed] Health News. 2000 Aug;6(8):6. Health News. 2000. PMID: 10948872 No abstract available.
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA, Dubois RN. Gupta RA, et al. Nat Rev Cancer. 2001 Oct;1(1):11-21. doi: 10.1038/35094017. Nat Rev Cancer. 2001. PMID: 11900248 Review.

See all similar articles

Cited by

Cell-type-specific roles for COX-2 in UVB-induced skin cancer.
Jiao J, Mikulec C, Ishikawa TO, Magyar C, Dumlao DS, Dennis EA, Fischer SM, Herschman H. Jiao J, et al. Carcinogenesis. 2014 Jun;35(6):1310-9. doi: 10.1093/carcin/bgu020. Epub 2014 Jan 27. Carcinogenesis. 2014. PMID: 24469308 Free PMC article.
CD44^high/ESA^low squamous cell carcinoma cell-derived prostaglandin E₂ confers resistance to 5-fluorouracil-induced apoptosis in CD44^high/ESA^high cells.
Shigeishi H, Hashikata M, Yokoyama S, Sakuma M, Murozumi H, Kato H, Rahman MZ, Seino S, Ishioka Y, Ohta K, Takechi M, Sugiyama M. Shigeishi H, et al. Int J Clin Exp Pathol. 2018 May 1;11(5):2356-2363. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938347 Free PMC article.
Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas.
Onguru O, Scheithauer BW, Kovacs K, Vidal S, Jin L, Zhang S, Ruebel KH, Lloyd RV. Onguru O, et al. Endocr Pathol. 2004 Spring;15(1):17-27. doi: 10.1385/ep:15:1:17. Endocr Pathol. 2004. PMID: 15067173
Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells.
Du J, Jiang B, Barnard J. Du J, et al. Neoplasia. 2005 Aug;7(8):761-70. doi: 10.1593/neo.04652. Neoplasia. 2005. PMID: 16207478 Free PMC article.
Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells.
Tani T, Ayuzawa R, Takagi T, Kanehira T, Maurya DK, Tamura M. Tani T, et al. Mol Cell Biochem. 2008 Aug;315(1-2):185-93. doi: 10.1007/s11010-008-9806-5. Epub 2008 Jun 10. Mol Cell Biochem. 2008. PMID: 18543083 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program